유방 생검 기기 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 유형별, 시술별, 용도별, 최종사용자별, 지역별 및 경쟁별 세분화(2020-2030년)
Breast Biopsy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Procedure, By Application, By End User, By Region and Competition, 2020-2030F
상품코드:1886284
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 유방 생검 디바이스 시장은 2024년에 10억 2,000만 달러로 평가되며, 2030년까지 CAGR 6.89%로 성장하며, 15억 2,000만 달러에 달할 것으로 예측됩니다. 유방생검 기기는 영상 진단 장비의 안내에 따라 바늘을 이용한 각종 시스템, 진공흡입식 시스템 등 의심되는 유방 병변에서 조직 샘플을 채취하여 확진 진단 검사를 시행하는 전문 장비입니다. 이 장비 세계 시장은 주로 유방암 발생률 증가, 조기 발견에 대한 대중의 인식 증가, 최소침습적 진단 방법에 대한 선호도 증가에 의해 주도되고 있습니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
10억 2,000만 달러
시장 규모 : 2030년
15억 2,000만 달러
CAGR : 2025-2030년
6.89%
가장 빠르게 성장하는 부문
생검침
최대 시장
북미
주요 시장 성장 촉진요인
세계에서 유방암 유병률이 증가함에 따라 효과적인 진단 솔루션에 대한 지속적이고 긴급한 수요가 발생하고 있으며, 이는 전 세계 유방 생검 기기 시장에 큰 영향을 미치고 있습니다. 발생률이 증가함에 따라 진단을 확인하고 치료 전략을 수립하기 위해 보다 빈번하고 정확한 생검이 요구되고 있습니다.
주요 시장 과제
첨단 생검 절차에 따른 막대한 비용과 고가의 영상 진단 장비에 대한 의존도는 세계 유방 생검 기기 시장의 성장에 큰 장벽으로 작용하고 있습니다. 이러한 재정적 장벽은 특히 자원이 한정된 지역이나 예산 제약이 심한 의료 시스템에서 이러한 필수 진단 툴의 도입을 제한함으로써 시장 확대를 직접적으로 가로막고 있습니다.
주요 시장 동향
인공지능(AI)과 머신러닝을 유방 생검 기기에 통합하는 움직임이 시장의 진단 정확도와 워크플로우 효율성을 변화시키고 있습니다. 이러한 고급 계산 기법은 영상 분석을 강화하여 방사선과 의사가 미세한 이상을 식별하고 양성 병변과 악성 병변을 보다 정확하게 구분할 수 있도록 돕습니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 유방 생검 기기 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
유형별(생검침, 가이던스 시스템, 생검대, 정위와이어, 어세이 키트, 액체생검 기기, 기타)
시술별(침생검, 개흉 수술 유방 생검, 액체 유방 생검)
용도별(조기 암검진, 치료 선택, 치료 경과 관찰, 재발 모니터링)
최종사용자별(병원·외과 센터, 유선 케어 센터, 영상 진단 클리닉·진단 센터)
지역별
기업별(2024)
시장 맵
제6장 북미의 유방 생검 기기 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 유방 생검 기기 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 유방 생검 기기 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 유방 생검 기기 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 유방 생검 기기 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 유방 생검 기기 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Hologic Inc.
Danaher Corporation
Becton, Dickinson and Company
Argon Medical Devices, Inc.
Guardant Health, Inc.
Merit Medical Systems, Inc.
Neogenomics Laboratories, Inc.
Sysmex Inostics, Inc.
Sterylab S.R.L.
Bio-Rad Laboratories Inc.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Breast Biopsy Devices Market, valued at USD 1.02 Billion in 2024, is projected to experience a CAGR of 6.89% to reach USD 1.52 Billion by 2030. Breast biopsy devices are specialized instruments utilized to extract tissue samples from suspicious breast lesions for definitive diagnostic examination, encompassing various needle-based and vacuum-assisted systems guided by imaging modalities. The global market for these devices is primarily driven by the increasing incidence of breast cancer, growing public awareness regarding early detection, and the expanding preference for minimally invasive diagnostic procedures.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.02 Billion
Market Size 2030
USD 1.52 Billion
CAGR 2025-2030
6.89%
Fastest Growing Segment
Biopsy Needles
Largest Market
North America
Key Market Drivers
The global breast biopsy devices market is significantly influenced by the increasing worldwide prevalence of breast cancer, creating a sustained and urgent demand for effective diagnostic solutions. The rising incidence necessitates more frequent and accurate biopsies to confirm diagnoses and guide treatment strategies. According to the World Cancer Research Fund, in 2022, there were 2,296,840 new cases of breast cancer among women globally, underscoring the critical need for advanced diagnostic tools.
Key Market Challenges
The substantial cost associated with advanced biopsy procedures and their reliance on expensive imaging modalities represents a significant impediment to the growth of the Global Breast Biopsy Devices Market. This financial barrier directly restricts market expansion by limiting the adoption of these essential diagnostic tools, particularly within resource-limited regions and healthcare systems operating under stringent budgetary constraints. The high capital investment required for state-of-the-art imaging equipment, such as specialized mammography units or MRI systems, coupled with the ongoing expenses for maintenance and skilled personnel, renders these advanced diagnostic pathways largely inaccessible to a significant portion of the global healthcare infrastructure.
Key Market Trends
The integration of Artificial Intelligence and Machine Learning into breast biopsy devices is transforming diagnostic accuracy and workflow efficiency within the market. These advanced computational methods enhance image analysis, aiding radiologists in identifying subtle anomalies and differentiating between benign and malignant lesions with greater precision. According to a EuroAIM/EuSoMII 2024 survey among members of the European Society of Radiology, 48% of respondents were already utilizing AI or planning its adoption, with a predominant expected impact on breast imaging. This widespread acceptance underscores the growing confidence in AI's capabilities.
Key Market Players
Hologic Inc.
Danaher Corporation
Becton, Dickinson and Company
Argon Medical Devices, Inc.
Guardant Health, Inc.
Merit Medical Systems, Inc.
Neogenomics Laboratories, Inc.
Sysmex Inostics, Inc.
Sterylab S.R.L.
Bio-Rad Laboratories Inc.
Report Scope:
In this report, the Global Breast Biopsy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Breast Biopsy Devices Market, By Type:
Biopsy Needles
Guidance Systems
Biopsy Tables
Localization Wires
Assay Kits
Liquid Biopsy Instruments
Others
Breast Biopsy Devices Market, By Procedure:
Needle Breast Biopsy
Open Surgical Breast Biopsy
Liquid Breast Biopsy
Breast Biopsy Devices Market, By Application:
Early Cancer Screening
Therapy Selection
Treatment Monitoring
Recurrence Monitoring
Breast Biopsy Devices Market, By End User:
Hospitals & Surgical Centers
Breast Care Centers
Imaging Clinics & Diagnostic Centers
Breast Biopsy Devices Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Breast Biopsy Devices Market.
Available Customizations:
Global Breast Biopsy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Breast Biopsy Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others)
5.2.2. By Procedure (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy)
5.2.3. By Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring)
5.2.4. By End User (Hospitals & Surgical Centers, Breast Care Centers, Imaging Clinics & Diagnostic Centers)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Breast Biopsy Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Procedure
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Breast Biopsy Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Procedure
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Breast Biopsy Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Procedure
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Breast Biopsy Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Procedure
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Breast Biopsy Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Procedure
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Breast Biopsy Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Procedure
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. France Breast Biopsy Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Procedure
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom Breast Biopsy Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Procedure
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy Breast Biopsy Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Procedure
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Breast Biopsy Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Procedure
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia Pacific Breast Biopsy Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Procedure
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Breast Biopsy Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Procedure
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Breast Biopsy Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Procedure
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Breast Biopsy Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Procedure
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Breast Biopsy Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Procedure
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Breast Biopsy Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Procedure
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. Middle East & Africa Breast Biopsy Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Procedure
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Breast Biopsy Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Procedure
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. UAE Breast Biopsy Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Procedure
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. South Africa Breast Biopsy Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Procedure
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. South America Breast Biopsy Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Procedure
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Breast Biopsy Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Procedure
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Colombia Breast Biopsy Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Procedure
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. Argentina Breast Biopsy Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Procedure
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Breast Biopsy Devices Market: SWOT Analysis
